BioHealth News Archive
Maryland Innovation Initiative Invests in Johns Hopkins Biomedical Projects
A Maryland corporation established to help accelerate the commercialization of new technologies has awarded nearly $300,000 to three Johns Hopkins-related projects that hold promise…
Read More
Johns Hopkins Spinoff Readies Medical Device For Sale
Clear Guide Medical LLC is readying its first product, a medical device used in minimally invasive ultrasound surgeries that will be for sale in early…
Read More
Lonza and Sartorius Stedim Biotech Enter Collaboration, Supply and Distribution Agreement in the Field of Cell Culture Media
Lonza today announced together with Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, a long-term global collaboration, supply and distribution agreement…
Read More
T2 Speaker Series
Join us for the upcoming Tech Transfer Speakers Series event on January 9th, 2013: "Do You Know the Export Control Regulations Impacting Your Technology…
Read More
Healthcare R&D in 2013: Globalization & collaboration will rule – MedCity News
Investment in research & development in the U.S. life science industry will turn a corner in 2013 after three years of reduced spending, if…
Read More
Mikulski to lead Senate Appropriations Committee – baltimoresun.com
In an unexpected move that could have significant implications for Maryland, Sen. Barbara A. Mikulski will be named the first female chair of the…
Read More
Maryland Innovation Initiative awards $300,000 in grants – Baltimore Business Journal
Two Johns Hopkins researchers and a medical device company are the first recipients of grants from the Maryland Innovation Initiative. The Innovation Initiative, a…
Read More
New economic development chief named for Md. – baltimoresun.com
Maryland's second-in-command on economic development matters will step into the top job in January when the current secretary leaves for the private sector, state…
Read More
Blend Therapeutics secures $16M from New Enterprise Associates, others – Washington Business Journal
Blend Therapeutics, a 1-year-old pre-clinical biotech focused on oncology drugs, has raised $16 million in Series B financing and named the former head of…
Read More
MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections
MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) for Progenics’ Clostridium…
Read More
NHLBI Funding and Research Opportunities, December 18, 2012
NHLBI Funding and Research Opportunities The following funding opportunities from the NHLBI or other components of the National Institutes of Health, might be of…
Read More
Noxilizer, Inc. Signs Lease to Relocate to University of Maryland BioPark
University of Maryland System’s Diverse Space Offerings Provide Sterilization Technology Company the Ability to Grow Locally Baltimore, MD, December 18, 2012 – The University…
Read More
INNoVATE 2012 Graduates
CONGRATULATIONS to 20 INNoVATE 2012 graduates—celebrating completion of their unique commercialization training program--co-sponsored by UMBC, NSF & JHU-- in Rockville last night. (See class…
Read More
University of Maryland, Baltimore raises record $650M – Baltimore Business Journal
University of Maryland, Baltimore said Monday it reached its $650 million fundraising goal, a record for the school. The campaign, launched in fiscal 2005,…
Read More
Little-hyped drugs from Human Genome Sciences, Sucampo win FDA nods – Washington Business Journal
Two little-hyped drugs developed by Human Genome Sciences Inc. and Sucampo Inc. (Nasdaq: SCMP) have won Food & Drug Administration nods. The approval of…
Read More